BIONIK
  • Solutions
    • InMotion® Therapy
    • InMotion® ARM
    • InMotion® ARM/HAND
    • InMotion® EVAL
    • InMotion® Connect
    • InMotion® for PT
    • InMotion® for OT
  • Evidence
    • Featured Webinars
    • Testimonials
    • Published Research
    • Clinical Guidelines
  • Blog
  • News
    • Media Coverage
    • Press Releases
  • Events
    • Conferences
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Investors
    • Careers
    • Contact
Select Page

Press Releases

Investors
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • News / Events

  • Press Releases
  • IR Calendar
  • Email Alerts

Bionik Laboratories Appoints Renaud Maloberti as Chief Commercial Officer

Jun 11, 2018

Bionik Laboratories Announces Rental Agreement with Tallahassee Memorial HealthCare for InMotion Arm Robotic System

May 16, 2018

Bionik Laboratories Issues Letter to Stockholders

Apr 3, 2018

Bionik Laboratories Appoints Peter Gerald Malone and Joseph Martin to its Board of Directors

Mar 20, 2018

Bionik Laboratories Corp. and Curexo Enter Exclusive Distribution Agreement for Sale of Robotic Rehabilitation Systems in U.S. and South Korea

Mar 7, 2018

Bionik Laboratories Reports Third Quarter Fiscal Year 2018 Financial Results

Feb 13, 2018

Bionik Laboratories Corp. Launches New Commercial Generation InMotion Arm Robotic System to Improve Rehabilitation for Stroke Survivors

Feb 5, 2018

Bionik Laboratories Corp. Appoints Andre Auberton-Herve as Chairman of Board of Directors

Jan 29, 2018

Bionik Laboratories Reports Second Quarter Fiscal Year 2018 Financial Results

Nov 14, 2017

Bionik Laboratories Corp. Announces Capital Raise through Issuance of Convertible Notes

Sep 21, 2017
RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...12

    Clinical Evidence

    • About
    • Investors
    • Disclaimer
    • Privacy Policy

    News + Events

    • Recent News
    • Events
    • Press Releases

    Support

    • Contact Us
    • Cleaning Procedures
    Global Headquarters

    80 Coolidge Hill Road
    Watertown, MA 02472
    United States
    Tel: +1 617.926.4800
    support@bioniklabs.com
    ©2022 BIONIK